Curated News
By: NewsRamp Editorial Staff
August 14, 2026
DM Clinical Research Celebrates 20 Years of Advancing Clinical Trials
TLDR
- DM Clinical Research's 20-year track record and 35+ sites offer sponsors proven enrollment performance and diverse patient access for faster trial success.
- DM Clinical Research integrates local physician relationships with centralized infrastructure across 35+ sites to deliver quality, speed, and consistent execution in clinical trials.
- DM Clinical Research expands access to clinical trials in underserved communities, helping more patients participate in life-changing research and improve healthcare for all.
- DM Clinical Research celebrates 20 years, enrolling over 35,000 patients across 32 therapeutic areas, with a network reaching 1.97 million people.
Impact - Why it Matters
This milestone underscores the critical role of clinical research networks in bringing new treatments to patients. For over two decades, DM Clinical has expanded access to trials, particularly in underserved communities, ensuring that diverse populations can participate in studies that may lead to life-saving therapies. Their growth reflects the increasing importance of patient-centric research and the need for efficient, high-quality trials to accelerate drug development. As the industry evolves, DM Clinical's continued investment in technology and community outreach will help shape the future of clinical research, benefiting patients and healthcare systems worldwide.
Summary
DM Clinical Research, a leading integrated clinical research network, is celebrating its 20th anniversary, marking two decades of expanding access to clinical trials and accelerating the development of innovative therapies. Founded in 2006 by Mohammad Millwala, the company has grown from a vision of patient-centered research to a network of more than 35 research sites, providing access to a patient population of 1.97 million individuals across 32 therapeutic areas. Over the past 20 years, DM Clinical has enrolled over 35,000 patients in clinical trials, helping to bring life-changing therapies to patients worldwide. The anniversary theme, 'Champions of Clinical Research: 20 Years of Impact,' reflects the company's commitment to teamwork, innovation, and dedication.
The company partners with leading pharmaceutical, biotechnology, and contract research organizations to conduct high-quality trials, emphasizing strong enrollment performance, diverse patient access, and operational excellence. DM Clinical continues to expand its presence in underserved communities, ensuring more patients can participate in trials. Its integrated operating model combines local physician relationships with centralized infrastructure, delivering quality and speed for sponsors. Industry recognition includes the SPRIA Award for vaccine enrollment, the Excellence in Patient Centricity Award, ViE's Best Clinical Trial Network Award, and the SCRS Site Spark Award. In 2025, CEO Mohammad Millwala received the SCRS Christine K. Pierre Site Impact Award for his leadership.
Guided by core values—Think Forward, Find a Way, Create Impact, Own It, and Win Together—DM Clinical looks to the future with plans for continued expansion, broader therapeutic expertise, and investment in innovative technologies. As the company enters its third decade, it remains focused on its mission to expand access to research and bring new therapies to patients faster, ensuring that clinical trials remain a viable option for diverse populations.
Source Statement
This curated news summary relied on content distributed by 24-7 Press Release. Read the original source here, DM Clinical Research Celebrates 20 Years of Advancing Clinical Trials
